KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
-7.4%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$246M
AUM Growth
+$246M
Cap. Flow
+$1.42M
Cap. Flow %
0.58%
Top 10 Hldgs %
97.51%
Holding
22
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
VNRX icon
VolitionRX
VNRX
$1.64M

Top Sells

1
ENLV icon
Enlivex Therapeutics
ENLV
$217K

Sector Composition

1 Healthcare 17.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
$202M 82.11% 4,397,838 – –
TOVX icon
2
Theriva Biologics
TOVX
$3.94M
$8.81M 3.58% 3,734,149 – –
AMPE
3
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$7.62M 3.1% 3,388,322 – –
CRBP icon
4
Corbus Pharmaceuticals
CRBP
$115M
$4.64M 1.88% 2,563,925 – –
ARCT icon
5
Arcturus Therapeutics
ARCT
$462M
$4.23M 1.72% 1,115,315 – –
ABEO icon
6
Abeona Therapeutics
ABEO
$350M
$3.48M 1.41% 1,359,767 – –
CEMP
7
DELISTED
Cempra, Inc.
CEMP
$3.17M 1.29% 180,800 – –
ADXS
8
DELISTED
Advaxis, Inc.
ADXS
$2.48M 1.01% 275,000 – –
LUMO
9
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.86M 0.76% 102,437 – –
VNRX icon
10
VolitionRX
VNRX
$74.2M
$1.64M 0.67% +461,538 New +$1.64M
KERX
11
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$934K 0.38% 200,000 – –
ADXSW
12
DELISTED
Advaxis, Inc. Warrants
ADXSW
$677K 0.27% 112,500 – –
NBSE
13
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$658K 0.27% 205,000 – –
ENLV icon
14
Enlivex Therapeutics
ENLV
$25M
$625K 0.25% 250,970 -87,140 -26% -$217K
ALDX icon
15
Aldeyra Therapeutics
ALDX
$351M
$569K 0.23% 135,800 – –
LSTA icon
16
Lisata Therapeutics
LSTA
$19.9M
$417K 0.17% 555,781 – –
CSBR icon
17
Champions Oncology
CSBR
$93.8M
$405K 0.16% 111,111 – –
GLMD icon
18
Galmed Pharmaceuticals
GLMD
$6.96M
$320K 0.13% 65,000 – –
EVOK icon
19
Evoke Pharma
EVOK
$8.49M
$283K 0.11% 55,660 – –
ZSAN
20
DELISTED
Zosano Pharma Corporation
ZSAN
$43K 0.02% 18,600 – –
APTO
21
DELISTED
Aptose Biosciences, Inc.
APTO
$34K 0.01% 11,933 – –